Skip to main content
OpenTrials
Completed

NCT Number: NCT01885026

Substance-focused SBI as a Complement to Internet-based Psychiatric Treatment: RCT

Objectives: This study evaluates the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet intervention for problematic alcohol and drug use offers self-screening, in-depth self-reporting, personalized feedback and treatment recommendations as well as an electronic diary. Progress over time is shown in diagrams detailing consumption levels.

Method: This is a two-armed randomized controlled design, measuring outcomes in terms of changes in problematic alcohol use up to one year after study recruitment. Participants with problematic alcohol use (AUDIT >7 for men and >5 for women) and/or problematic drug use (DUDIT > 1 for both men and women) are randomized into one of two groups: T1, eScreen referral or Control group. Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6 and 12 months.

The hypothesis is that the group receiving the eScreen intervention will reduce their alcohol/drug use to a larger extent than the control group at follow-up compared to the baseline level.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Substance Use Disorders (SUD) Chemically-Induced Disorders Mental Disorders Substance-Related Disorders

Age range

15 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Karolinska institutet, Department of Clinical Neuroscience, Center for Psychiatric Research

Stockholm, 11364, Sweden

About this study

This study evaluated the efficacy of eScreen for internet psychiatry patients treated for major depressive disorder, panic anxiety and social phobia. The eScreen brief Internet intervention for problematic alcohol and drug use offers self-screening, in-depth self-reporting, personalized feedback and treatment recommendations as well as an electronic diary. Progress over time is shown in diagrams detailing consumption levels. The design was a two-armed randomized controlled design, measuring outcomes in terms of changes in problematic alcohol use up to one year after study recruitment. Participants with problematic alcohol use (AUDIT >7 for men and >5 for women) and/or problematic drug use (DUDIT > 1 for both men and women) were randomized into one of two groups: T1, eScreen referral or Control group. Outcomes on alcohol and drug use as well as health-related symptoms are assessed after 3, 6 and 12 months.

The hypothesis was that the group receiving the eScreen intervention would reduce their alcohol/drug use to a larger extent than the control group at follow-up compared to the baseline level. The results have not yet been analyzed due to technical issues. However, qualitative interviews have been conducted with participants and our intention is to publish the qualitative results in tandem with the quantitative results available.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

AUDIT >7 for men and AUDIT >5 for women, and/or DUDIT >0

Exclusion criteria

DUDIT = 0 and AUDIT <8 (men) or <6 (women)

Treatment and study plan

eScreen

Behavioral

Access to the eScreen platform offering assessment of alcohol and drug use, with automated feedback on problematic or non-problematic use. Follow-up over time based on user needs.

Assessment only of alcohol and drug use.

Behavioral

Assessment of alcohol and drug use at baseline and follow-up.

Internet-based treatment for depression or anxiety

Behavioral

Internet-based treatment for primary diagnoses of depression, panic anxiety or social phobia.

Primary outcomes

  1. Change in the total AUDIT-C score

    Time frame: 3, 6 and 12 months

    The primary outcome measure for this trial is the change in the total AUDIT score for the first three AUDIT questions, as a measure of alcohol consumption only, referred to as the AUDIT-C.

Secondary outcomes

  1. Alcohol Use Disorders Identification Test (AUDIT)

    Time frame: 3, 6 and 12 months

    Change in total AUDIT score, as a summarized measure of alcohol use (including alcohol consumption and alcohol-related problems).

Other outcomes

  1. Changes in health parameters over time

    Time frame: 3, 6 and 12 months

    Health-related questions on wellbeing, sleep, concentration, energy, social life, sadness and current life meaning, etc.

Sponsors and collaborators

Lead sponsor

Karolinska Institutet

Other

Registry information

Official study title

Substance-use Focused Screening and Brief Intervention as a Complement to Internet-based Psychiatric Treatment for Depression, Panic Disorder or Social Phobia: A Randomized Controlled Trial

Acronym: eScreeniPsy

Important dates

Study start
2013
Primary completion
2016
Study completion
2016
First posted
Jun 24, 2013
Registry last updated
Oct 4, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.